Results 21 to 30 of about 2,398,984 (347)

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2

open access: yesClinical and Translational Science, 2021
Tocilizumab is an IL‐6 receptor antagonist with the ability to suppress the cytokine storm in critically ill patients infected with severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2).
Russell M. Petrak   +25 more
doaj   +1 more source

Infectious diseases epidemiology [PDF]

open access: yesJournal of Epidemiology and Community Health, 2006
In this glossary the authors have reviewed old and new terms contemporarily used in the infectious disease epidemiology. Many of these concepts were established throughout the 19th century and at the beginning of the 20th century (classic terms), however, the meanings of old terms have been revised and new terms are continually being added.
Mauricio L, Barreto   +2 more
openaire   +2 more sources

Back Matter

open access: yesIndonesian Journal of Tropical and Infectious Disease, 2021
Indonesian Journal of Tropical and Infectious Disease
doaj   +5 more sources

Treatment of Acute Osteomyelitis with Once-Weekly Oritavancin: A Two-Year, Multicenter, Retrospective Study

open access: yesDrugs - Real World Outcomes, 2020
Background Acute osteomyelitis is typically caused by Gram-positive pathogens, commonly antibiotic-resistant Staphylococcus species. Standard antibiotic treatment is challenging due to required multiple daily doses, therapeutic drug monitoring, and ...
Nicholas W. Van Hise   +7 more
doaj   +1 more source

Front Matter

open access: yesIndonesian Journal of Tropical and Infectious Disease, 2021
Indonesian Journal of Tropical and Infectious Disease
doaj   +5 more sources

Heavy Schistosomiasis Associated With Poor Short-Term Memory and Slower Reaction Times in Tanzania Schoolchildren [PDF]

open access: yes, 2002
Cross-sectional studies of the relationship between helminth infection and cognitive function can be informative in ways that treatment studies cannot.
Department for Infectious Disease Epidemiology,Imperial College Shool of Medicine,London, Department for Infectious Disease
core  

Predicting Chronicity in Children and Adolescents With Newly Diagnosed Immune Thrombocytopenia at the Timepoint of Diagnosis Using Machine Learning‐Based Approaches

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives To identify predictors of chronic ITP (cITP) and to develop a model based on several machine learning (ML) methods to estimate the individual risk of chronicity at the timepoint of diagnosis. Methods We analyzed a longitudinal cohort of 944 children enrolled in the Intercontinental Cooperative immune thrombocytopenia (ITP) Study ...
Severin Kasser   +6 more
wiley   +1 more source

Macrolides: A Canadian Infectious Disease Society Position Paper

open access: yesCanadian Journal of Infectious Diseases, 2001
Since the introduction of erythromycin in 1965, no new compounds from the macrolide antimicrobial class were licensed in Canada until the 1990s. Clarithromycin and azithromycin, since their introduction, have become important agents for treating a number
S McKenna   +2 more
doaj   +1 more source

Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Approximately 10% of patients with Ewing sarcoma (EwS) have pathogenic germline variants. Here, we report two cases: first, a novel germline pathogenic variant in partner and localizer of BRCA2 (PALB2) in a patient with a late EwS relapse. Its impact on homologous recombination is demonstrated, and breast cancer risk is discussed.
Molly Mack   +12 more
wiley   +1 more source

Patient‐Level Barriers and Facilitators to Inpatient Physical Therapy in Adolescents and Young Adults With a Hematological Malignancy: A Qualitative Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Despite their increased risk for functional impairment resulting from cancer and its treatments, few adolescents and young adults (AYAs) with a hematological malignancy receive the recommended or therapeutic dose of exercise per week during inpatient hospitalizations.
Jennifer A. Kelleher   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy